4-Biphenylac-Cys(Me)-D-Arg-Phe-(2-phenylethyl)amide |
| Catalog No.GA20414 |
Cathepsin L inhibitor VI, inhibitor with nanomolar potency (Ki = 19 nM) and higher selectivity for inhibiting cathepsin L over cathepsin K (310-fold) and cathepsin B (210-fold). The tripeptide-sized inhibitor mimicks the mode of autoinhibition of procathepsin L.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 478164-48-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Cathepsin L inhibitor VI, inhibitor with nanomolar potency (Ki = 19 nM) and higher selectivity for inhibiting cathepsin L over cathepsin K (310-fold) and cathepsin B (210-fold). The tripeptide-sized inhibitor mimicks the mode of autoinhibition of proca
Average Rating: 5 (Based on Reviews and 36 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *